2017
DOI: 10.1016/j.jemermed.2016.09.010
|View full text |Cite
|
Sign up to set email alerts
|

Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
2
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 40 publications
1
2
0
1
Order By: Relevance
“…It may also be the best available data well into the future, as evidenced by the researchers’ laudable, ultimately Herculean, 6‐year effort to generate even these data. While the results nominally favor the use of procainamide for pharmacologic conversion of stable VT and align with a recent review of the existing literature, a true answer will remain elusive until higher‐quality RCTs are performed. Electrical cardioversion likely remains the most effective therapy for VT .…”
Section: Caveatssupporting
confidence: 54%
“…It may also be the best available data well into the future, as evidenced by the researchers’ laudable, ultimately Herculean, 6‐year effort to generate even these data. While the results nominally favor the use of procainamide for pharmacologic conversion of stable VT and align with a recent review of the existing literature, a true answer will remain elusive until higher‐quality RCTs are performed. Electrical cardioversion likely remains the most effective therapy for VT .…”
Section: Caveatssupporting
confidence: 54%
“…VT is considered most common wide complex tachycardia with more than 120 bpm that originates in the distal bundle of his ventricular myocardium. A wide QRS interval of more than 120 ms was observed with no regularly occurring P wave to QRS association (Long & Koyfman, 2017). Polymorphic VT can result in a malignant tachyarrhythmia changing QRS pattern.…”
Section: Ventricular Tachycardiamentioning
confidence: 99%
“…Amiodarone is a class III antiarrhythmic medication commonly used in the emergency department (ED) and other critical care settings to treat several types of arrhythmias while also serving as a fixture of the Advanced Cardiac Life Support algorithm. [1] Its mechanism of action primarily involves blocking potassium channel currents during myocyte repolarization with additional effects on betaadrenergic receptors and both sodium and calcium channel blockade. [2] One of amiodarone's less known complications is the development of acute hepatotoxicity with intravenous (IV) administration.…”
Section: Dear Editormentioning
confidence: 99%